Q4 EARNINGS: Quest beats forecasts; Zimmer faces more exchange rate pain
This article was originally published in Clinica
Quest Diagnostics finished the year strongly, with its fourth quarter beating analyst expectations. Q4 sales of $1.88bn increased 7% year-on-year, marking the firm’s third consecutive quarter of growth, and were above analyst consensus of $1.85bn. Adjusted earnings of $1.08 per share were up from $1.03 per share in Q4 2013, and trumped analyst forecasts of $1.04.